Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Venous thromboembolism (VTE) is a frequent complication of COVID-19, so that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with COVID-19 is well established. However, the incidence of VTE after discharge and whether postdischarge thromboprophylaxis is beneficial and safe are unclear. In this prospective observational single-center study, we report the incidence of VTE 6 weeks after hospitalization and the use of postdischarge thromboprophylaxis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Semin Thromb Hemost

Title: Seminars in thrombosis and hemostasis

Publisher: Georg Thieme Verlag KG

ISSN (Electronic): 1098-9064

ISSN (Print): 0094-6176

Publication date (Electronic): Jun 2021

Volume: 47

Issue: 4

Affiliations

[1 ] Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.

[2 ] Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.

[3 ] Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

[4 ] Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Leuven, Belgium.

[5 ] Department of Cardiovascular Diseases and Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.

[6 ] The Outbreak Research Team, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

[7 ] Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.

[8 ] Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium.

[9 ] Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium.

[10 ] Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.

[11 ] Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

[12 ] Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.

[13 ] Department of CHROMETA, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium.

[14 ] Medical Intensive Care, University Hospitals Leuven, Leuven, Belgium.

Article

DOI: 10.1055/s-0041-1727284

PubMed ID: 33893631

SO-VID: f18f0020-798e-4ba8-900b-f4a9e057d280

History

Data availability:

Comments

Comment on this article

scite_

Cited by 29

See all cited by